Lykos Therapeutics ("Lykos"), a company dedicated to transforming mental healthcare, today announced a reorganization to best support the company as...
Eisai Co., Ltd. and Biogen Inc. are pleased to announce that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved the hum...
Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Livdelzi® (seladelpar) fo...
Lilly Seaport Innovation Center (LSC) serves as the central hub for Lilly's genetic medicines efforts and houses the first East Coast Lilly Gateway Labs ...
Composition-of-matter patent covers the therapeutic use of arsenic salts and metal ions through various routes of administration. Enriched IP portfoli...
Mangoceuticals, Inc. \ a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of ...
Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it obtained CE mark in Eu...
Hypoparathyroidism is a rare endocrine disease with multi-organ impacts affecting an estimated 70,000 to 90,000 people in the United States Ascendi...
Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, announced that patient dosing has begun for...
Vertex Pharmaceuticals (Nasdaq: VRTX) announced a reimbursement agreement with NHS England for eligible transfusion-dependent beta thalassemia (TDT...
Partnership Expands Reach of C2N’s Precivity™ Blood Tests in Over 75 Countries to Transform Alzheimer’s Disease Early Diagnosis...
Agreement will see NewBridge Pharmaceuticals act as a multi-country distributor in four countries across the Middle East and North Africa (MENA) ...
Thermo Fisher Scientific Inc., the world leader in serving science, announced that its SeCore™ CDx HLA A Sequencing System has been granted 5...
llumina a global leader in DNA sequencing and array-based technologies, today announced it has expanded its oncology menu for NovaSeq™ X Series custo...
© 2024 Biopharma Boardroom. All Rights Reserved.
